Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.68
-0.69 (-8.24%)
At close: Aug 28, 2026, 4:00 PM EDT
7.79
+0.11 (1.40%)
After-hours: Aug 28, 2026, 7:46 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $1.99 billion as of August 28, 2026. Its market cap has increased by 235.18% in one year.
Market Cap
1.99B
Enterprise Value
2.14B
1-Year Change
235.18%
Ranking
Category
Stock Price
$7.68
ChartMarket Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $1.99B, a decrease of -72.42%. That is a compound annual growth rate of -20.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 1.99B | 139.99% |
| Dec 31, 2025 | 831.00M | -39.62% |
| Dec 31, 2024 | 1.38B | -16.38% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
| Nov 20, 2020 | 7.23B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.10B |
| Hemab Therapeutics Holdings | 2.09B |
| ADMA Biologics | 2.09B |
| Stoke Therapeutics | 2.04B |
| Zenas BioPharma | 2.04B |
| Zymeworks | 2.01B |
| Agios Pharmaceuticals | 1.99B |
| Generate Biomedicines | 1.97B |